A critical evaluation of vancomycin for treatment of bacterial meningitis.
Ahmed
A
A
St. John's Mercy Medical Center, St. Louis, MO, USA.
D000328:Adult; D000818:Animals; D000900:Anti-Bacterial Agents / Q000134:cerebrospinal fluid / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D002986:Clinical Trials as Topic; D006801:Humans; D007223:Infant; D015552:Injections, Intralesional; D007275:Injections, Intravenous; D016920:Meningitis, Bacterial / Q000188:drug therapy* / Q000382:microbiology; D011817:Rabbits; D016896:Treatment Outcome; D014640:Vancomycin / Q000134:cerebrospinal fluid / Q000627:therapeutic use*
D000900:Anti-Bacterial Agents; D014640:Vancomycin